Skip to main content
Premium Trial:

Request an Annual Quote

Sequenom May Pay Non-Management Directors Up to $36K in 2005; Outlines Bonuses for Top Brass

NEW YORK, March 25 (GenomeWeb News) - By the end of 2005, Sequenom may have paid its non-management board members as much as $36,000 as the result of a compensation agreement recently signed by the company's board, according to documents filed with the SEC on Wednesday.

 

In the same document, Sequenom also outlined a 2005 bonus schedule for top management.

 

The company's board of directors approved on March 17 to pay its six non-management members $1,500 apiece for each "special" board meeting attended in person and $1,000 for each special meeting attended electronically, the SEC document said. Additionally, non-management board members will receive $1,000 for each special committee meeting attended personally or electronically, the document added.

 

Sequenom does not pay non-management directors to attend board meetings or committee meetings, the company said.

 

There is typically one special board meeting per year and as many as five special committee meeting per year, said a Sequenom spokesperson. Special committee meetings include audit committee, compensation committee, and nomination and governance committee meetings, she added.

 

Sequenom also said that its CEO and executive vice president of sales and marketing will receive as their 2005 bonuses 50 percent of their base salaries for the year. Bonuses for the chief financial officer and chief medical officer will be 35 percent of their total base salary; vice residents will receive 25 percent; and director-level employees 15 percent.

 

Sequenom's bonus program is based on "the achievement of total revenue and maximum cash burn targets and MassArray system sales and product launch milestones, completion of specified compliance objectives, and other criteria the disclosure of which would reveal confidential business information and plans of the registrant," the company said in the SEC filing.

The Scan

Gone, But Now Reconstructed SARS-CoV-2 Genomes

In a preprint, a researcher describes his recovery of viral sequences that had been removed from a common database.

Rare Heart Inflammation Warning

The Food and Drug Administration is adding a warning about links between a rare inflammatory heart condition and two SARS-CoV-2 vaccines, Reuters reports.

Sandwich Sampling

The New York Times sent tuna sandwiches for PCR analysis.

Nature Papers Describe Gut Viruses, New Format for Storing Quantitative Genomic Data, More

In Nature this week: catalog of DNA viruses of the human gut microbiome, new dense depth data dump format to store quantitative genomic data, and more.